Connex-2
Research payments
$2,937,609
Through program year 2025, $2,937,609 in research payments was reported against Connex-2, across 284 payments.
- Paid by (largest first)
- Boehringer Ingelheim Pharmaceuticals, Inc.; Boehringer Ingelheim Canada Ltd.Ltee; Boehringer Ingelheim International GmbH
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $656,127 | 61 |
| 2024 | Research | $2,234,433 | 34 |
| 2021 | Research | $47,049 | 189 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Ronald Brenner Rockville Centre, NY Named on 30 payments
- Yaneicy Gonzalez Rojas Coral Gables, FL Named on 27 payments
- Mohammad Asim Nisar Okeechobee, FL Named on 18 payments
- Armen Goenjian Long Beach, CA Named on 17 payments
- Arifulla Khan Bellevue, WA Named on 16 payments
- Diane Highum Costa Mesa, CA Named on 16 payments
- Gustavo Alva Costa Mesa, CA Named on 15 payments
- Mamta Sapra Salem, VA Named on 13 payments
- Elizabeth Zarate-Rowell Seal Beach, CA Named on 13 payments
- Jelena Kunovac Oceanside, CA Named on 13 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.